Wanbury Ltd, one of the fastest growing pharma companies in the domestic market, has entered into the osteoporosis & gynaecology related calcium deficiency market with the launch of Cdense - Calcium Orotate, a mineral transporter. Cdense will be available in tablet form of 740 mg dosage.
The details can be read here.
No comments:
Post a Comment